Search research articles
Contact Us
Filters
Showing results (121-130 of 131) with videos related to
Page
of 14
Sort By:
Bone Marrow Transplantation
|
March 24, 2015
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
F Sahebi, S Iacobelli, A V Biezen, et al.
Bone Marrow Transplantation
|
October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation
G Gahrton, H Svensson, B Björkstrand, et al.
Journal of Internal Medicine
|
December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
C Craddock, J Versluis, M Labopin, et al.
Bone Marrow Transplantation
|
January 27, 2015
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial
S Iacobelli, L C de Wreede, S Schönland, et al.
Leukemia
|
April 28, 2016
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party
M Sobh, M Michallet, G Gahrton, et al.
British Journal of Haematology
|
May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres
G Gahrton, H Svensson, M Cavo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)
S Dietrich, A Boumendil, H Finel, et al.
Bone Marrow Transplantation
|
March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes
R Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation
|
September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
C Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation
|
January 22, 2019
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
W Wiktor-Jedrzejczak, J Drozd-Sokolowska, D J Eikema, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 131) with videos related to
Sort By:
Page
of 14
Bone Marrow Transplantation
|
March 24, 2015
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
F Sahebi, S Iacobelli, A V Biezen, et al.
Bone Marrow Transplantation
|
October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation
G Gahrton, H Svensson, B Björkstrand, et al.
Journal of Internal Medicine
|
December 8, 2017
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
C Craddock, J Versluis, M Labopin, et al.
Bone Marrow Transplantation
|
January 27, 2015
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial
S Iacobelli, L C de Wreede, S Schönland, et al.
Leukemia
|
April 28, 2016
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party
M Sobh, M Michallet, G Gahrton, et al.
British Journal of Haematology
|
May 22, 2001
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres
G Gahrton, H Svensson, M Cavo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)
S Dietrich, A Boumendil, H Finel, et al.
Bone Marrow Transplantation
|
March 21, 2017
Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes
R Martino, A Henseler, M van Lint, et al.
Bone Marrow Transplantation
|
September 12, 2017
Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
C Scheid, L de Wreede, A van Biezen, et al.
Bone Marrow Transplantation
|
January 22, 2019
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
W Wiktor-Jedrzejczak, J Drozd-Sokolowska, D J Eikema, et al.
Page
of 14